Carcinosarcoma: Clinical Trials

3 trials for Carcinosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3
Phase 22Terminated 2

Follow Carcinosarcoma: new trials by email Literature Review of Carcinosarcoma trials Research Report on Carcinosarcoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
INCB099280, axitinib - Advanced Solid Tumors
Phase 1 / Phase 2TerminatedIncyte Corporation52024-04-162026-06-04
(VELA) Study of BLU-222 in Advanced Solid Tumors
BLU-222, Carboplatin, Ribociclib - Advanced Solid Tumors, HR+ Breast Cancer
Phase 1TerminatedBlueprint Medicines Corporation502022-04-072025-11-28
A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors
Rebastinib, Paclitaxel - Locally Advanced or Metastatic Solid Tumor
Phase 1 / Phase 2TerminatedDeciphera Pharmaceuticals, LLC1772018-10-252024-12-27

Narrower conditions

Ovarian Neoplasms (3)  ·  Endometrial Neoplasms (2)  ·  Adenocarcinoma Of Esophagus (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Breast Neoplasms (1)  ·  Cystadenocarcinoma, Serous (1)  ·  Fallopian Tube Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Stomach Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)  ·  Uterine Neoplasms (1)  ·  Vaginal Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Adnexal Diseases (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Gonadal Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Complex and Mixed (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Ovarian Diseases (3)

Interventions

Axitinib (1)  ·  Carboplatin (1)  ·  DCC-2036 (1)  ·  Fulvestrant (1)  ·  Paclitaxel (1)  ·  rebastinib (1)  ·  ribociclib (1)

Sponsors

Blueprint Medicines Corporation (1)  ·  Deciphera Pharmaceuticals, LLC (1)  ·  Incyte Corporation (1)

Countries

United Kingdom (2)  ·  United States (2)  ·  Italy (1)

Top investigators

Philomena Colucci (1)

NIH funding

2023 (1)